Elizabeth Galan, MD
Family Medicine · Torrington, CTNPI 1972545689
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (54.4%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.5% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2020 at $10,136 and has fallen 92.0% since, to $807 in 2025. Among family medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $42.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Boehringer Ingelheim$869
- Lilly USA, LLC$752
- Novo Nordisk$708
- Bayer$642
- Amgen$480
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,75445%
- Education$420%
- Gifts$9,30254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $10,851 |
| Boehringer Ingelheim | 48 | $869 |
| Lilly USA, LLC | 40 | $752 |
| Novo Nordisk | 36 | $708 |
| Bayer | 18 | $642 |
| Amgen | 25 | $480 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $358 |
| AstraZeneca | 19 | $307 |
| Johnson & Johnson | 10 | $273 |
| GSK | 10 | $248 |
| Lundbeck LLC | 10 | $200 |
| Exact Sciences | 7 | $155 |
| Therapeuticsmd, Inc. | 4 | $142 |
| Amneal Pharmaceuticals LLC | 7 | $138 |
| Pfizer | 6 | $100 |
| Antares Pharma, Inc. | 6 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Vertical Pharmaceuticals, LLC | 5 | $67 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Eisai Inc. | 4 | $62 |
| Radius Health, Inc. | 4 | $59 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Merck | 3 | $45 |
| Almatica Pharma LLC | 2 | $42 |
| Merz North America, Inc. | 1 | $40 |
| Acerus Pharmaceuticals Corporation | 3 | $40 |
| E.r. Squibb & Sons, L.L.C. | 1 | $37 |
| Astellas Pharma US Inc | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,098 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 72 | $83,259 |
| MysolinePrimidone | 11 | $62,748 |
| OzempicSemaglutide | 61 | $59,246 |
| ProliaDenosumab | 30 | $52,601 |
| JanuviaSitagliptin Phosphate | 22 | $29,244 |
| EliquisApixaban | 18 | $25,728 |
| TrintellixVortioxetine Hydrobromide | 20 | $14,491 |
| MounjaroTirzepatide | 12 | $12,625 |
| NamzaricMemantine Hcl/Donepezil Hcl | 13 | $7,349 |
| SynthroidLevothyroxine Sodium | 69 | $5,599 |
| Memantine Hcl | 24 | $3,352 |
| Metoprolol Succinate | 221 | $2,172 |
| Atorvastatin Calcium | 273 | $2,158 |
| Estradiol | 24 | $1,936 |
| Levothyroxine Sodium | 241 | $1,524 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $869 | $83,25972 claims |
| Novo NordiskOzempic | $708 | $59,24661 claims |
| AmgenProlia | $480 | $52,60130 claims |
| MerckJanuvia | $45 | $29,24422 claims |
| PfizerEliquis | $100 | $25,72818 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $358 | $14,49120 claims |
| AbbVieNamzaric, Synthroid, Armour Thyroid | $10,851 | $13,64593 claims |
| Lilly USA, LLCMounjaro | $752 | $12,62512 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $138 | $2,166278 claims |
| Almatica Pharma LLCSertraline Hcl | $42 | $56371 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 family medicine providers in Connecticut.
Other family medicine in Torrington
- Bradley RosenbergTorrington$11K
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Helar CamposNew London$29K
- Kristin GianniniVernon$28K
- Sanjeev RaoBridgeport$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.